Drs. Barnett and Brujic Discuss the Keratoconus Testing Cons -

Name: Drs. Barnett and Brujic Discuss the Keratoconus Testing Consensus Statement
Uploaded: 2021-07-21T04:00:00+00:00
Duration: 14 min 25 s
Description: Drs. Melissa Barnett and Mile Brujic define keratoconus and discuss the incidence of prevalence of keratoconus in refractive surgery patients. They also di

Media formats available:

Details

Presenters

Overview
Drs. Melissa Barnett and Mile Brujic define keratoconus and discuss the incidence of prevalence of keratoconus in refractive surgery patients. They also discuss diagnostic test criteria that should be used to identify keratoconus patients. They also discuss how genetic testing for keratoconus may help catch refractive surgery candidates who may be at risk for developing keratoconus. Discussion includes the future of genetic testing in todays optometric practice.
This activity is supported by an unrestricted educational grant from Avellino.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Define etiology and progression of keratoconus, understand how refractive surgery can exacerbate these conditions, and review the impact this has on visual outcomes and quality of life
- Describe the prevalence of the refractive surgery patients developing keratoconus in various patient populations
- Identify the accuracy of various conventional and new genetic testing metrics for identifying refractive surgery patients who may be at risk for developing keratoconus
- Review treatment options for refractive surgery candidates who have or are likely to develop keratoconus
- Recommend diagnostic work-up protocols and pre-emptive testing indications for various groups of refractive surgery patients to maximize the diagnosis of keratoconus suspects
Accreditation
Sponsored by:
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This activity, COPE Activity Number 122174, is accredited by COPE for continuing education for optometrists.
This course is approved for .25 hours of CE.
Course #: 73478-AS
Activity ID: 122174
Participation Method
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Faculty and Disclosures
Melissa Barnett, OD, FAAO, FSLS, FBCLA
Principal Optometrist
University of California, Davis, Eye Center
Sacramento, CA

Mile Brujic, OD, FAAO
Partner
Premier Vision Group
Bowling Green, OH

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Melissa Barnett, OD, FAAO, FSLS, FBCLA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: Azura, Bruder, Cooper Vision, Dompe, Everyday Contacts, EyeEco, Mojo Vision, Novartis, Ocusoft, Oyster Point, Percept, and Raayonnova. Advisory Board/Consultant: Visus Therapeutics. Advisory Board/Speaker's Bureau: AAB, Acculens, Allergan, Bausch + Lomb, Contamac, Gas Permeable Lens Institute, JJVC Vistakon, RVL Pharmaceuticals, Scleral Lense Education Society, Synergeyes, Tangible Science, Tarsus. Speaker's Bureau: BCLA, Science Based Health, Sjogren's Syndrom Foundation, and STAPLE Program.
Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala Pharmaceuticals, Novartis, Sun Pharmaceutical Industries, VMax Vision, and Zea Vision. Speaker’s Bureau: Allergan, Bausch + Lomb Health, Kala Pharmaceuticals, Novartis, Optovue, Sun Pharmaceutical Industries, and Zea Vision. Grant/Research Support: Contamac.
The Evolve and The Fundingsland Group planners have no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Avellino.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 07/21/2021
Expiration Date: 07/21/2022

Melissa Barnett, OD, FAAO, FSLS, FBCLA

Guest

Mile Brujic, OD, FAAO

Guest

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
MinuteCE®
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
MinuteCE®
The Neverending Journey: A 66-Year-Old Patient Who Has Undergone Several Rounds of Tea Tree Oil–Based Treatment
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Closing the Loop: Structured Follow-Up and Patient Communication
Closing the Loop: Structured Follow-Up and Patient Communication
MinuteCE®
Closing the Loop: Structured Follow-Up and Patient Communication
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit
Key Takeaways and Practice Integration
Key Takeaways and Practice Integration
MinuteCE®
Key Takeaways and Practice Integration
Douglas K. Devries, OD; Cecelia Koetting, OD, FAAO
1.00 program credit
- Douglas K. Devries, OD
- Cecelia Koetting, OD, FAAO
1.00 program credit

Drs. Barnett and Brujic Discuss the Keratoconus Testing Consensus Statement

Recommended

Title